Taylor M A, DiBlasi S L, Bender R M, Santoian E C, Cha S D, Dennis C A
Department of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ 08015.
Cathet Cardiovasc Diagn. 1994 Jul;32(3):249-53. doi: 10.1002/ccd.1810320310.
Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.
呼吸衰竭是最罕见且严重的药物不良反应之一。低分子右旋糖酐（右旋糖酐-40）在冠状动脉血管成形术和冠状动脉内支架置入术中是一种有用的辅助抗血小板药物。我们报告了静脉输注右旋糖酐-40后发生成人呼吸窘迫综合征的情况。
